Recent quarters

Latest 2 quarters

Quarter	EPSReported / estimate	RevenueReported / estimate	Reaction
Q2 FY2026 2026-08-11	-0.18 / -0.10 -71.4%†	$13.8M / $11.4M +21.0%	-4.08% ⁦-4.33⁩ pts vs SPY Session 2026-08-12
Q1 FY2026 2026-05-13	-0.07 / -0.14 +50.0%†	$14.4M / $10.9M +32.6%	+14.53% ⁦+13.74⁩ pts vs SPY Session 2026-05-14

Reported / estimate

Q2 FY2026 · 2026-08-11-4.08%
EPS-0.18 / -0.10-71.4%†
Revenue$13.8M / $11.4M+21.0%
Q1 FY2026 · 2026-05-13+14.53%
EPS-0.07 / -0.14+50.0%†
Revenue$14.4M / $10.9M+32.6%

Reaction is the close of the reacting session versus the previous close. The gap to SPY is in percentage points.

Aquestive Therapeutics, Inc. (AQST) earnings

Name: Aquestive Therapeutics, Inc. (AQST) Earnings Call
Start: 2026-11-04

2026-11-04

In 8 daysQ3 FY2026AMC· Expected date

77 days ago

⁦+21.0%⁩Revenue Beat

2026-08-11Q2 FY2026AMC

⁦-4.08%⁩

⁦-4.33⁩ pts vs SPY

Session ⁦2026-08-12⁩